EQUASHIELD® logo — EQUASHIELD Closed System Transfer Device and EQUASHIELD Mund...

EQUASHIELD®

EQUASHIELD Closed System Transfer Device and EQUASHIELD Mundus HD

Founded 2009 United States Port Washington, United States 138 employees Secondary Market Total: $300.00M Health Care, Medical Devices +1

General Information

Company Name EQUASHIELD®
Founded Year 2009
Location United States Port Washington, United States
Employees 138
Industries Health Care, Medical Devices, Robotics
Funding Stage Secondary Market
Social

BounceWatch is an independent company data service, not affiliated with EQUASHIELD®. To contact EQUASHIELD®, visit equashield.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EQUASHIELD® compare?

A PDF of EQUASHIELD® and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EQUASHIELD® soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EQUASHIELD®

Equashield is a privately held medical device company based in the United States that has gained recognition for its innovative products in the Health Care and Robotics industries. The company, founded in 2004, is known for its flagship products - the EQUASHIELD Closed System Transfer Device and the EQUASHIELD Pro Hazardous Drug Compounding Robot. Equashield's main focus lies in providing a Closed System Transfer Device (CSTD) for the safe handling of hazardous drugs. Its portfolio also includes a range of closed syringes, adapters, connectors, and tubing sets, catering to different stages from compounding in pharmacy to administration in nursing. The company's dedication to safety and ease-of-use is evident in its commitment to ensuring FDA clearance, CE approval, and compliance with ISO 13485 quality system management. Notably, the company recently received a significant $300.00M Secondary Market investment on 06 October 2022 from Nordic Capital, signifying investor confidence in Equashield's vision and products. The investment is expected to fuel further growth and innovation within the company. Equashield's mission to protect healthcare workers from risks associated with exposure to hazardous drugs aligns with the growing emphasis on occupational safety in the healthcare sector. With its expanded production facility and commitment to regulatory compliance, Equashield aims to provide medical professionals with the confidence to serve others without compromising their own health and safety.

Business keywords: medical device company, closed system transfer device, hazardous drugs handling, healthcare worker safety, FDA cleared products, ISO 13485 compliant, clean room production facility, IV automation, robotics in healthcare, pharmaceutical safety, occupational safety, hazardous drug exposure, medical equipment innovation, patient safety

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Secondary Market $300.00M 1
Nordic Capital
06 Oct 2022

EQUASHIELD® Alternatives & Competitors

View All Alternatives
EQUASHIELD® vs
The Brewer Company
The Brewer Company United States

Bringing the safest, most advanced exam room solutions & ergonomic seating to the marketplace.

100 employees
Health Care, Medical Devices
EQUASHIELD® vs
ENvizion Medical
ENvizion Medical United States

Personalized Navigation Technologies for Safe Enteral Feeding Tube Placement

Venture round
15 employees
Health Care, Medical Devices
EQUASHIELD® vs

Specialized in Medical Device Software Development, Testing, Remediation, and Cybersecurity

39 employees
Biotechnology, Health Care

FAQ About EQUASHIELD®

EQUASHIELD Closed System Transfer Device and EQUASHIELD Mundus HD
EQUASHIELD® was founded in 2009.
EQUASHIELD® is headquartered in Port Washington, United States.
EQUASHIELD® operates in Health Care, Medical Devices and Robotics. Its work centres on medical device company, closed system transfer device, hazardous drugs handling and healthcare worker safety.
EQUASHIELD® has approximately 138 employees.
EQUASHIELD® has completed 1 funding round, raising a total of $300.00M. The latest funding stage is Secondary Market.
Top alternatives and competitors to EQUASHIELD® include The Brewer Company, ENvizion Medical , CriTech Research, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EQUASHIELD® and The Brewer Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EQUASHIELD®, https://bouncewatch.com/company/equashield, updated 20 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes